http://www.zacks.com/stock/news/533490/mallinckrodts-stratagraft-tissue-phase-iii-data-positive?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-533490
Sep 24, 2019 - Mallinckrodt's (MNK) experimental StrataGraft regenerative tissue meets goals in a late-stage study for the treatment of burns.
zc:-5328908901600380170
0
https://seekingalpha.com/article/4293240-teva-find-relevancy-cannabis?source=feed_tag_israel
Sep 24, 2019 - Israel’s Teva Pharmaceutical Industries Ltd. share price sells a notch above its 19 years low. Investor sentiment is low too. I do not recommend retail investors buy this stock now.TEVA still has sign
0
sa:-2717439964464699654
0
http://www.zacks.com/stock/news/552912/astrazenecas-fasenra-gets-fda-nod-for-self-administration?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-552912
Oct 07, 2019 - The FDA approval of the self-administration option and auto-injector of AstraZeneca's (AZN) Fasenra is supported by data from the phase III GRECO study and the phase I AMES study
zc:-8051215070960627364
0
http://www.zacks.com/stock/news/553574/teva-pharmaceutical-industries-ltd-teva-gains-as-market-dips-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-553574
Oct 07, 2019 - Teva Pharmaceutical Industries Ltd. (TEVA) closed at $6.98 in the latest trading session, marking a +0.14% move from the prior day.
zc:3756166554752495784
0
https://www.cnbc.com/2019/10/11/cramer-lightning-round-mgm-has-spectacular-gambling-sports-plans.html
Oct 11, 2019 - Jim Cramer takes calls and opines on viewer stock picks of the day in rapid speed.
0
cnbc:-3166075253490873424
0
http://feeds.benzinga.com/~r/benzinga/~3/ggRLhSSoZus/jim-cramer-shares-his-thoughts-on-teva-pharmaceutical-mgm-resorts-and-more
Oct 12, 2019 - On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't like Teva Pharmaceutical Industries Ltd (NYSE: TEVA). He would sell the stock.
read more
0
benzinga:7508206507349479354
0
http://www.zacks.com/stock/news/565810/jj-jnj-beats-on-q3-earnings-as-sales-rise-ups-2019-view?cid=CS-ZC-FT-analyst_blog|earnings_article-565810
Oct 15, 2019 - J&J (JNJ) comes up with encouraging third-quarter 2019 results.
zc:7126679237584863740
0
https://www.fool.com/investing/2019/10/21/heres-why-teva-pharmaceutical-soared-today.aspx?source=iedfolrf0000001
Oct 21, 2019 - The company announced an unexpectedly favorable settlement in a lawsuit related to the opioid epidemic.
0
fool:-5777804874937500154
0
https://www.cnbc.com/2019/10/21/teva-shares-surge-after-announcing-global-opioid-settlement.html
Oct 21, 2019 - Under that deal, Teva would donate $23 billion in opioid addiction treatment drugs and pay $250 million over 10 years.
0
cnbc:-2961804568823243381
0
https://www.cnbc.com/2019/10/24/tevas-proposed-opioid-settlement-could-cost-drugmaker-pennies-on-the-dollar.html
Oct 24, 2019 - Teva Pharmaceutical's proposed $23 billion drug giveaway to settle thousands of U.S. opioid lawsuits will likely cost the company a fraction of that figure due to how it has valued those medicines, according to a Reuters review.
0
cnbc:6581684553045085393
0